Walnut Creek, CA; Boston, MA, Oct. 04, 2022 (GLOBE NEWSWIRE) — Darkish Horse Consulting Group (“DHC”), the main international consultancy to the cell and gene remedy (“CGT”) trade, and WestView Capital Companions (“WestView” ), a Boston-based progress fairness agency, are happy to collectively announce that WestView has accomplished a progress funding in DHC.
Headquartered in Walnut Creek, California, DHC is the trade main follow of skilled consultants specializing completely within the subject of cell and gene remedy. DHC leverages its staff of extremely skilled consultants to assist purchasers obtain their strategic and operational targets, spanning from high-level company technique improvement to detailed technical implementation and regulatory roadmapping. DHC has a key deal with chemistry, manufacturing and controls (“CMC”) and regulatory technique, providing providers comparable to manufacturing assist, course of improvement, analytical improvement, high quality administration system evaluation, system improvement and regulatory assist, amongst others. DHC’s quickly rising international staff presents unequalled experience to therapeutic builders, traders, and instruments, know-how and repair suppliers within the CGT house.
“This funding from WestView will permit us to proceed to develop to fulfill the quickly increasing want for skilled steerage within the subject of cell and gene remedy. Our foundational goal is to make use of our experience to assist the acceleration of cell and gene therapies to sufferers, and this partnership expands the assets we’ll have in assist of that aim,” stated DHC CEO and Founder Anthony Davies, Ph.D. “What drew us to WestView was their data of the service and healthcare areas, mixed with their overriding philosophy of long-term collaborative partnerships centered round belief in and assist of their portfolio firms,” added Katy Spink, Ph.D., DHC COO and Managing Companion.
“Our funding in Darkish Horse displays WestView’s dedication to partnering with main life science service firms led by passionate and skilled entrepreneurs,” stated Greg Thomas, Basic Companion at WestView, who will be a part of DHC’s Board of Administrators. “Anthony has constructed a powerful staff that positions Darkish Horse because the main consultancy within the cell and gene remedy trade. We’re thrilled to associate with them and sit up for serving to Darkish Horse develop and broaden its service providing,” famous Thomas. “Cell and gene remedy is thrilling know-how that has the chance to form the way forward for drugs. However with that comes new challenges and complexity, significantly in CMC and regulatory technique, and Darkish Horse is completely suited to serve purchasers’ wants on this sector because it grows and evolves,” added Jeff Clark, a Principal at WestView, who may also be a part of the Firm’s board. “We’re excited concerning the alternative that lies forward for Darkish Horse.”
WestView was represented by Latham & Watkins LLP. DHC was represented by Fenwick and West LLP.
About Darkish Horse Consulting Group
Darkish Horse Consulting Group, a world firm with places of work in each California and London, was based in 2014 with the aim of accelerating cell and gene therapies by unmatched consulting experience. DHC’s collective data spans manufacturing assist, course of improvement and comparability, analytical improvement, quantitative modeling, high quality methods, system improvement, regulatory assist, mission and program administration, market analysis, and financing and diligence. DHC presents an unmatched understanding of the challenges confronted by cell and gene remedy builders and is ready to apply greatest practices from this and different industries to handle a various vary of consumer wants.
About WestView Capital Companions
WestView Capital Companions, a Boston-based non-public fairness agency targeted completely on center market progress firms, manages roughly $1.7 billion in capital throughout 4 funds. WestView companions with present administration groups to sponsor minority and majority recapitalizations, progress, and consolidation transactions in industries comparable to software program and IT providers, healthcare know-how and outsourcing, enterprise providers, client, and industrial progress. WestView focuses on investing in firms with income of not less than $10 million and working income between $3 and $25 million. For extra info, please go to www.wvcapital.com.
CONTACT: Darkish Horse Consulting Group 1255 Deal with Blvd, Suite 230; Walnut Creek, CA 94597 email@example.com